β1-Adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome

International Journal of Cardiology

Volumn 118, Issue 2, 2007, Pages 197-202

  Paavonen, Kristian J ^a   Swan, Heikki ^a   Piippo, Kirsi ^a   Laitinen, Päivi ^a   Fodstad, Heidi ^a   Sarna, Seppo ^a   Toivonen, Lauri ^a   Kontula, Kimmo ^a   Viitasalo, Matti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Beta adrenergic receptor; Long QT syndrome; Polymorphism; Potassium channel; QT interval

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; KCNQ1 PROTEIN, HUMAN; POTASSIUM CHANNEL KCNQ1; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANAMNESIS; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; QT INTERVAL; RISK ASSESSMENT; SYMPTOM; ADOLESCENT; AGED; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FINLAND; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; MUTATION; REFERENCE VALUE; REGRESSION ANALYSIS; RISK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FINLAND; GENOTYPE; HUMANS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 34247133966     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.06.050     Document Type: Article

References (32)

1. Sanguinetti M.C., Jiang C., Curran M.E., and Keating M.T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81 (1995) 299-307
2. Sanguinetti M.C., Curran M.E., Zou A., et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384 (1996) 80-83
3. Antzelevitch C., Shimizu W., Yan G.X., et al. The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 10 (1999) 1124-1152
4. Schwartz P.J., Priori S.G., Spazzolini C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103 (2001) 89-95
5. Shimizu W., Ohe T., Kurita T., and Shimomura K. Differential response of QTU interval to exercise, isoproterenol, and atrial pacing in patients with congenital long QT syndrome. Pacing Clin Electrophysiol 14 (1991) 1966-1970
6. Viitasalo M., Paavonen K.J., Swan H., Kontula K., and Toivonen L. Effects of epinephrine on right ventricular monophasic action potentials between LQT1 and LQT2 forms of long QT syndrome. Pacing Clin Electrophysiol 28 (2005) 219-227
7. Nakagawa M., Ooie T., Baiqing O., et al. Gender differences in autonomic modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol 16 (2005) 278-284
8. Shimizu W., and Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long QT syndrome. Circulation 98 (1998) 2314-2322
9. Shimizu W., and Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 35 (2000) 778-786
10. Priori S., Schwartz P.J., Napolitano C., et al. Risk stratification in the long QT syndrome. N Engl J Med 348 (2003) 1866-1874
11. Viitasalo M., Oikarinen L., Swan H., et al. Ratio of late to early T-wave peak amplitude in 24-h electrocardiographic recordings as indicator of symptom history in patients with long-QT syndrome types 1 and 2. J Am Coll Cardiol 47 (2006) 112-120
12. Priori S.G., Napolitano C., Schwartz P.J., et al. Association of Long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292 (2004) 1341-1344
13. Villain E., Denjoy I., Lupoglazoff J.M., et al. Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J 25 (2004) 1405-1411
14. Frielle T., Collins S., Daniel K.W., Caron M.G., Lefkowitz R.J., and Kobilka B.K. Cloning of the cDNA for the human beta-1-adrenergic receptor. Proc Natl Acad Sci U S A 84 (1987) 7920-7924
15. Maqbool A., Hall A.S., Ball S.G., and Balmforth A.J. Common polymorphisms of beta-1-adrenoceptor: identification and rapid screening assay. Lancet 353 (1999) 897
16. Leineweber K. Beta-adrenergic polymorphisms in human cardiovascular disease. Ann Med 36 (2003) 64-69
17. Fodstad H., Swan H., Laitinen P., et al. Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med 36 (2004) 53-63
18. Bazett H. An analysis of the time-relations of electrocardiograms. Heart 7 (1920) 353-370
19. Miettinen O.S. Confounding and effect modification. Am J Epidemiol 100 (1974) 350-353
20. Small K.M., Wagoner L.E., Levin A.M., Kardia S.L.R., and Liggett S.B. Synergistic polymorphisms of beta-1- and alfa-2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347 (2002) 1135-1142
21. Mason D.A., Moore J.D., Green S.A., and Liggett S.B. A gain-of-function polymorphism in a G-protein coupling domain of the human beta-1-adrenergic receptor. J Biol Chem 274 (1999) 12670-12674
22. La Rosee K., Huntgeburth M., Rosenkranz S., Böhm M., and Schnabel P. The Arg389Gly beta-1-adrenoceptor gene polymorphism determines contractile response to catecholamines. Pharmacogenetics 14 (2004) 711-716
23. Sandilands A.J., O'Shaughnessy K.M., and Brown M.J. Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta-1-adrenoceptors versus Gly389 beta-1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 138 (2003) 386-392
24. Rathz D.A., Brown K.M., Kramer L.A., and Liggett S.B. Amino acid 49 polymorphisms of the human beta-1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 39 (2002) 155-160
25. Molenaar P., Rabnott G., Yang I., et al. Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta-1-adrenergic receptor polymorphisms in human right atrium in vitro. J Am Coll Cardiol 40 (2002) 1275-1282
26. Buscher R., Belger H., Eilmes K.J., et al. In-vivo studies do not support a major functional role for the Gly389Arg beta-1-adenoceptor polymorphism in humans. Pharmacogenetics 11 (2001) 199-205
27. Noda T., Takaki H., Kurita T., et al. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J 23 (2002) 975-983
28. Ackerman M.J., Khositseth A., Tester D.J., Hejlik J.B., Shen W.K., and Porter C.B. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 77 (2002) 405-406
29. Swan H., Viitasalo M., Piippo K., Laitinen P., Kontula K., and Toivonen L. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 34 (1999) 823-829
30. Viswanathan P.C., Shaw R.M., and Rudy Y. Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study. Circulation 99 (1999) 2466-2474
31. Shimizu W., Ohe T., Kurita T., et al. Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation 84 (1991) 1915-1923
32. Volders P.G., Vos M.A., Szabo B., et al. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc Res 46 (2000) 376-392